December 18, 2023
New JZ Modifier for Zero Discarded Drugs & Biologicals in Single-Use Containers – Revised
While the JZ modifier was effective and optional for use with claims for dates of service on or after January 1, 2023, it is now required for use in situations noted below for claims with dates of service on or after July 1, 2023.
- For dates of service on or after July 1, 2023, suppliers must append the JZ modifier to claim line(s) for drugs and biologicals from single-dose containers that are administered by the supplier when there are no unused or discarded amounts.
- Beginning January 1, 2024, suppliers who dispense but do not actually administer single-dose container drugs that are separately payable under Part B are required to report the JZ modifier on the claim. Suppliers must report the JZ modifier in these cases to ensure claims can be appropriately processed.
CMS has published Discarded Drugs and Biologicals – JW Modifier and JZ Modifier Policy FAQs to provide background information and instructions on the discarded drug policy.
Report the JW modifier when billing for unused and discarded amounts of drugs and biologicals from single-dose containers that are administered by the supplier and document the amount of discarded drugs in Medicare beneficiaries’ medical records.
The JZ modifier information will be updated in the “Modifiers” section of the following LCD-related Policy Articles:
- External Infusion Pumps - Policy Article (A52507)
- Intravenous Immune Globulin - Policy Article (A52509)
- Nebulizers - Policy Article (A52466)
Publication History:
February 2, 2023 | Originally published |
June 15, 2023 | Updated to include information about supplier administration. |
December 18, 2023 | Updated to include changes effective January 1, 2024. |